microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease. - Wikidata - wikimedia - TriplyDB

microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease.

microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease.

http://www.wikidata.org/entity/Q36610305

about

Getting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-Review Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic Review MicroRNA-155 enhances T cell trafficking and antiviral effector function in a model of coronavirus-induced neurologic disease Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicine.Mechanisms of Parkinson's disease-related proteins in mediating secondary brain damage after cerebral ischemia.Combination of ginsenoside Rb1 and Rd protects the retina against bright light-induced degeneration Microglial-derived microparticles mediate neuroinflammation after traumatic brain injury.MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.Epigenetic regulation in Parkinson's disease.Non-coding RNAs and neuroprotection after acute CNS injuries.MicroRNA 155 and viral-induced neuroinflammation.Glucocerebrosidase deficiency in dopaminergic neurons induces microglial activation without neurodegeneration.Induction of miR-155 after Brain Injury Promotes Type 1 Interferon and has a Neuroprotective Effect.Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages Long non-coding RNA MALAT1 contributes to cell apoptosis by sponging miR-124 in Parkinson disease.miR-135b Plays a Neuroprotective Role by Targeting GSK3β in MPP+-Intoxicated SH-SY5Y Cells.Cocaine-mediated downregulation of microglial miR-124 expression involves promoter DNA methylation.miR-155 induces ROS generation through downregulation of antioxidation-related genes in mesenchymal stem cells.miR-124-3p attenuates MPP+-induced neuronal injury by targeting STAT3 in SH-SY5Y cells.MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease.MicroRNA-30e regulates neuroinflammation in MPTP model of Parkinson's disease by targeting Nlrp3.microRNAs in Parkinson's Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches.Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease.MicroRNA-124 regulates the expression of MEKK3 in the inflammatory pathogenesis of Parkinson's disease.MicroRNAs in Parkinson's disease and emerging therapeutic targets.MicroRNA-induced silencing in epilepsy: Opportunities and challenges for clinical application.miR-155 Dysregulation and Therapeutic Intervention in Multiple Sclerosis.Cocaine-Mediated Downregulation of miR-124 Activates Microglia by Targeting KLF4 and TLR4 Signaling.Neurotoxins as Preclinical Models for Parkinson's Disease.Microglia Polarization, Gene-Environment Interactions and Wnt/β-Catenin Signaling: Emerging Roles of Glia-Neuron and Glia-Stem/Neuroprogenitor Crosstalk for Dopaminergic Neurorestoration in Aged Parkinsonian Brain.Silencing a Multifunctional microRNA Is Beneficial for Stroke Recovery.Targeting α-Synuclein as a therapy for Parkinson's disease: The battle begins.Anti-Parkinson Potential of Silymarin: Mechanistic Insight and Therapeutic Standing.Differential expression of miRNA 155 and miRNA 146a in Parkinson's disease patients Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise Microglia Response During Parkinson's Disease: Alpha-Synuclein Intervention

P2860

Q28079707-37F1FDD5-5DA8-4457-AE4F-9609C735641E Q28080047-B3B4F6C7-A76E-4FEA-A9D2-EBF10F5FBF94 Q28596130-3E850FC0-FC5B-416E-81AA-056EBDF4DF70 Q30394681-0A3022F0-29E1-43D7-8256-C44CC552D58B Q33727623-3453DF22-15DD-4C78-96C7-715C4A1CADC0 Q33921077-32751ED1-2B99-4230-B1B2-73CDEC50A3D7 Q37700810-0428B2EA-082B-4E07-A1C6-509519FCFF24 Q37702119-F9715C8A-2F9E-4B7A-9419-BCE3BCBDE13C Q38881221-9F752ACC-34BA-4BA8-A499-B56D43F36B36 Q39107969-3E10BCCB-5A68-4F95-9856-7D3D94DF2ED8 Q39111001-F8FE4D20-F5E0-4C65-90C4-2C5A8ECDA5BD Q40196691-0DA5737A-ECD7-4E39-AD2D-FFBDC3A6D597 Q41160124-4BAC19C3-0140-46E2-911E-0DA83CB8CA78 Q41488989-4C192782-0064-4909-82CE-6A526B273E87 Q41812140-58901756-AC56-4741-ACBB-E0F85FB9F365 Q42177761-16BEE916-346E-41DE-9C66-A35396760203 Q42975744-37DB6906-4C7D-4733-AE6A-67781B236CEB Q46297305-70CEB1AC-C0BC-4D7C-9F67-44EBEE17C613 Q46299429-B3ED390F-C5CD-4211-978E-776BBACABD05 Q47102033-06D4B131-7391-4B97-A0BC-ADFEC98F4A06 Q47259139-16E6CF51-96AB-46D1-84A0-F3FFFF8E4DDA Q47564833-41091DBF-0300-433D-99CF-C3D583880329 Q47575506-4925C8CE-4723-46DF-B639-BDBAB013E8F5 Q47867288-888385AB-7E91-4F1D-A0E6-32D2FA1885A4 Q47870847-67B7101E-78B3-4915-8C02-C99D53C6F2D2 Q47888887-F6DCB18F-6A18-4E3F-8D49-4A40D238E5CA Q48108346-11A7F785-D290-4C59-BE86-09EAD52A9082 Q48181933-CCADF671-E0AF-4DE6-AFB7-4D062C09E6DD Q48291354-48DA8F01-EB66-44A0-AC30-7549D8E4E867 Q51767077-2BDA4044-D533-48FC-A8BD-4B804AE96458 Q52661746-0696BD84-FE55-4B51-BC95-47AAFF204859 Q53813036-54AB5112-F881-4F45-982E-69D432678662 Q55360734-76A55CB5-D3FB-40A0-B048-59C52DC814D5 Q58740022-D1088BC6-ABEE-4ACD-9A1A-157843EAE856 Q58764682-911FE5FF-1E10-4F12-B5A0-9601820BDA98 Q58799080-ACF10F13-B6E9-4EB9-BD00-07D4C5653144

P2860

microRNA-155 Regulates Alpha-Synuclein-Induced Inflammatory Responses in Models of Parkinson Disease.

http://www.wikidata.org/entity/Q36610305

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

microRNA-155 Regulates Alpha-S ...... n Models of Parkinson Disease.

@ast

microRNA-155 Regulates Alpha-S ...... n Models of Parkinson Disease.

@en

type

label

microRNA-155 Regulates Alpha-S ...... n Models of Parkinson Disease.

@ast

microRNA-155 Regulates Alpha-S ...... n Models of Parkinson Disease.

@en

prefLabel

microRNA-155 Regulates Alpha-S ...... n Models of Parkinson Disease.

@ast

microRNA-155 Regulates Alpha-S ...... n Models of Parkinson Disease.

@en

P1433

Q36610305-59D71435-AF82-4D34-BE25-FE797265F16C

P1476

Q36610305-F144019D-217F-4782-94B9-6E94960D3A65

P2093

Q36610305-67AC7AD4-126E-4A3F-A6D9-76A0215AE467

Q36610305-86D20316-D835-470B-A46F-780067EB19E3

Q36610305-C318AB08-A99D-419E-9783-10DE5BCAC8D0

Q36610305-EE8E45C4-B708-49D2-80E6-3257C987D9CF

P2860

Q36610305-01AE29CF-3419-45B4-96F0-F2B0EF8CA77E

Q36610305-0349260D-61B7-4072-B3AE-03160953C633

Q36610305-03EE4F99-3A45-4B44-B40F-0D1E7A13CC62

Q36610305-14A8906A-49A7-4589-8FA6-11FB76B80CAF

Q36610305-1668AE2D-FFD1-4DD1-B766-89752BCE4689

Q36610305-220BDBB1-3878-4A42-AB11-7AD0EEC15A81

Q36610305-261373F0-F172-48E8-B952-06B2BADE9F02

Q36610305-28715541-5E65-4DE3-80DB-ACB97145AA08

Q36610305-292AA54D-A222-45DD-9626-F7534242CAB4

Q36610305-31618E8C-7FD8-4F93-8553-3270A33244D8

P304

Q36610305-D8E87150-6355-4272-A9C0-B5FC25F5E3FE

P31

Q36610305-47101025-A953-449C-B1FB-19ADADC56251

P356

Q36610305-59092FFF-DFED-4945-A550-FAEAB7B3A96C

P407

Q36610305-02C92C11-BF4F-4EEF-9896-3C22925E1798

P433

Q36610305-58B024BA-0DBE-4D7A-A00F-79856ACC8B1F

P478

Q36610305-6C6F9DEA-1ED2-44F3-AEBD-76C708B70190

P50

Q36610305-095C1EB7-DC4B-4D55-AAD6-851FD0E955D0

Q36610305-4CD13FBD-D88F-4AF1-BF74-1D7C27DE4076

Q36610305-C52986E4-443F-4DB6-9424-1F54A124965F

Q36610305-E64C41DF-D4B6-4161-9291-8DE3AADD27EF

P577

Q36610305-55325C30-958E-4508-85D3-30FE710ECD0D

P698

Q36610305-37FAD810-554F-498C-ACA3-BE5812F6762D

P921

Q36610305-25761A2E-283D-463E-AF57-D4DF38725DCD

Q36610305-2AD0F637-EECD-4826-970A-63F736FAB1DA

Q36610305-9A8E58B5-A02A-4DD7-82D0-5969874A491A

Q36610305-AAFF4F84-8D28-4AF8-B5FB-105E88CB6ADB

P932

Q36610305-DFC807C3-4811-477D-96E0-A19576FBB12D

P356

JNEUROSCI.3900-15.2016

P1433

Journal of Neuroscience

P1476

microRNA-155 Regulates Alpha-S ...... in Models of Parkinson Disease

@en

P2093

Aaron D Thome

http://www.w3.org/2001/XMLSchema#string

Ashley S Harms

http://www.w3.org/2001/XMLSchema#string

David G Standaert

http://www.w3.org/2001/XMLSchema#string

Laura A Volpicelli-Daley

http://www.w3.org/2001/XMLSchema#string

P2860

Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu

Inositol phosphatase SHIP1 is a primary target of miR-155

MicroRNAs are universal regulators of differentiation, activation, and polarization of microglia and macrophages in normal and diseased CNS

Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice.

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease.

Regulation of the germinal center response by microRNA-155

Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

Neuroinflammation in Parkinson's disease: a target for neuroprotection?

Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice

MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47.

P304

2383-2390

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1523/JNEUROSCI.3900-15.2016

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

David G. Standaert

Laura A Volpicelli-Daley

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26911687

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

4764660

http://www.w3.org/2001/XMLSchema#string